Professur für Immunologie

Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy (2022) Hoffmann M, Sidarovich A, Arora P, Krueger N, Nehlmeier I, Kempf A, Graichen L, et al. Journal article Augmented neutralization of SARS-CoV-2 Omicron variant by boost vaccination and monoclonal antibodies (2022) Schulz S, Hoffmann M, Roth E, Pracht K, Burnett DL, Mazigi O, Schuh W, et al. Journal article Krüppel-like factor 2 controls IgA plasma cell compartmentalization and IgA responses (2022) Wittner J, Schulz S, Steinmetz T, Berges J, Hauke M, Channell WM, Cunningham AF, et al. Journal article The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic (2022) Hoffmann M, Krüger N, Schulz S, Cossmann A, Rocha C, Kempf A, Nehlmeier I, et al. Journal article No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2 (2022) Arora P, Kempf A, Nehlmeier I, Graichen L, Winkler MS, Lier M, Schulz S, et al. Journal article IL-33-induced metabolic reprogramming controls the differentiation of alternatively activated macrophages and the resolution of inflammation (2021) Faas M, Ipseiz N, Ackermann J, Culemann S, Grüneboom A, Schröder F, Rothe T, et al. Journal article B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination (2021) Arora P, Sidarovich A, Krüger N, Kempf A, Nehlmeier I, Graichen L, Moldenhauer AS, et al. Journal article A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants (2021) Vesper N, Ortiz Y, Bartels-Burgahn F, Yang J, De La Rosa K, Tenbusch M, Schulz S, et al. Journal article A pair of non‐competing neutralizing human monoclonal antibodies protecting from disease in a SARS‐CoV‐2 infection model (2021) Peter AS, Roth E, Schulz S, Fraedrich K, Steinmetz T, Damm D, Hauke M, et al. Journal article, Original article The role of glucose transporter type 1 in plasma cells (2021) Bierling T, Gumann A, Van Schie K, Wichert M, Hauke M, Wittner J, Schuh W, et al. Conference contribution